Accuray nets FDA nod for dose calculation tool

Radiotherapy firm Accuray said that its Monte Carlo dose calculation algorithm has received U.S. Food and Drug Administration (FDA) 510(k) clearance.

The software is now available worldwide, according to the Sunnyvale, CA-based firm.

By staff writers
September 11, 2007

Related Reading

Accuray shows strong Q3 gains, May 2, 2007

Accuray inks deal with Siemens, April 12, 2007

Accuray notches CyberKnife treatment milestone, April 3, 2007

Accuray scores revenues gains in fiscal Q2, March 16, 2007

Accuray IPO raises $171 million, February 14, 2007

Copyright © 2007

Page 1 of 461
Next Page